340M is old news because yahoo data is unreliable and not always up to date. They've used some for acquisition and to increase their R&D. So the number is almost 300M. For the analysis we need to adjust R&D expenditures to be in alignment to their tracker industry. What's Garmin R&D on % revenue? If we use Garmin % then FIT R&D spend is about 50M annual. Now if we make the adjustment to Garmin, then you'll notice that FIT can take 250M R&D adjustment and put that into the bottom line and that makes them profitable. Their business then should be worth 2x revenue like a standard CPG (3B market cap, and right now they are not...that's the financial analysis to show where FIT should be). However, instead of doing accounting and finance, Park backed up everything into Digital Health so they don't become a dinosaur. Good CEO play the long-term game. Bad CEO play the quarter to quarter game. My company has no visionary...I have more vision than them, but since I'm only middle management and not senior/executive management, I don't want to talk too much and be a thorn.
Why did I compare FIT to MDT? We all know MDT is the world largest pure play medtech. FIT may become the 1st 21st century MedTech. MedTech in the 21st century is not about consumption and the increasing rate of disease among the population. 21st century Medtech is about personalize healthcare, and improving health outcomes. FIT has a vision to be exactly that -- Make the world healthier. So if you do a value chain analysis...wha
t happens when a companies cut your future earnings by going up the value chain? You become stagnant. The value chain for MedTech are based upon these factors:
1) Sedentary work (office job)
2) Over consumption of process food (fast food/junk food/box food)
3) Sedentary lifestyle (no money to travel, workout, unsafe environment, etc...)
The combination of this effect is an emergence of an obese population. Obesity drives cost of healthcare spending. Obesity related disease are cardiovascular disease, diabetes, and cancer. These are the largest medtech companies in the world. Now, IVD companies also benefit because they help diagnose these disease. A healthier population would significantly reduce the consumption level of all these medtech companies, and drive down the cost of healthcare. They would make Obamacare work. The net effect is a stagnation in old-MedTech industry.
lol
i have a finance degree
trust me.
since they are public traded company
all their finanical stuff is listed and post
to answer your question: how much cash they have?
they have $341,966,000 ish
https://finance.yahoo.com/quote/FIT/balance-sheet?p=FIT
operating at a lose currently
lol
you are comparing fitbit to medtronic
that like orange and steak
they are not the same thing